
Sign up to save your podcasts
Or
EP. 212: Today I’m joined by Dr. Spencer Nadolsky, obesity specialist, Lipidologist, and founder of Vineyard, a cutting-edge direct care platform. We’re diving deep into the conversation you’ve been asking for: the real story behind GLP-1s, obesity as a chronic disease, and why treating it goes far beyond weight loss.
We break down everything from proper dosing, common side effects, and the dangers of vanity prescribing to the systemic issues with telemedicine and PBMs. Dr. Nadolsky and I also discuss strength training, preserving muscle mass, and how GLP-1s may support metabolic and cardiovascular health beyond their FDA indications.
This episode cuts through the noise and misinformation. If you care about metabolic health, this one’s essential.
Topics Discussed:
What are the real benefits of GLP-1 medications beyond weight loss?
Is obesity truly a chronic disease, and how should it be treated?
What are the risks of GLP-1 vanity dosing and fast titration?
How do GLP-1s impact muscle mass and metabolic health?
Why are telemedicine and PBMs problematic for obesity treatment?
Sponsored By:
On This Episode We Cover:
00:00:00 – Introduction
00:02:48 – GLP-1 Dosing
00:06:35 – Side Effects of Vanity Dosing
00:08:51 – Reducing GLP-1 Dosing
00:12:27 – Med Spas & Telemedicine Risks
00:14:20 – Slow Titration for Better Tolerance
00:18:44 – Pharma Profits & Overdosing
00:20:49 – Obesity Treatment Pre & Post GLP-1s
00:27:58 – Obesity Is a Chronic Disease
00:32:45 – Defining obesity
00:36:16 – The Role of Genetics in Obesity
00:38:59 – Lifestyle Factors Beyond Genetics
00:40:46 – Insurance Barriers & PBM Costs
00:44:37 – Anti-GLP-1 Bias in Healthcare
00:46:22 – Why Strength Training Matters
00:51:39 – New Doctors & Role of AI
00:53:38 – Protecting Muscle on GLP-1s
00:58:55 – No Shortcuts to Health
01:02:01 – The Vineyard
Show Links:
Glp-1s Can Help Employers Lower Medical Costs In 2 Years, New Study Finds
Further Listening
GLP1 Uncovered FREE 4 Part Video Series
Ozempic Done Right Playlist
EP. 202 | The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knap
Check Out Dr. Spencer
Vineyard
Website
Podcast
Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
4.9
14831,483 ratings
EP. 212: Today I’m joined by Dr. Spencer Nadolsky, obesity specialist, Lipidologist, and founder of Vineyard, a cutting-edge direct care platform. We’re diving deep into the conversation you’ve been asking for: the real story behind GLP-1s, obesity as a chronic disease, and why treating it goes far beyond weight loss.
We break down everything from proper dosing, common side effects, and the dangers of vanity prescribing to the systemic issues with telemedicine and PBMs. Dr. Nadolsky and I also discuss strength training, preserving muscle mass, and how GLP-1s may support metabolic and cardiovascular health beyond their FDA indications.
This episode cuts through the noise and misinformation. If you care about metabolic health, this one’s essential.
Topics Discussed:
What are the real benefits of GLP-1 medications beyond weight loss?
Is obesity truly a chronic disease, and how should it be treated?
What are the risks of GLP-1 vanity dosing and fast titration?
How do GLP-1s impact muscle mass and metabolic health?
Why are telemedicine and PBMs problematic for obesity treatment?
Sponsored By:
On This Episode We Cover:
00:00:00 – Introduction
00:02:48 – GLP-1 Dosing
00:06:35 – Side Effects of Vanity Dosing
00:08:51 – Reducing GLP-1 Dosing
00:12:27 – Med Spas & Telemedicine Risks
00:14:20 – Slow Titration for Better Tolerance
00:18:44 – Pharma Profits & Overdosing
00:20:49 – Obesity Treatment Pre & Post GLP-1s
00:27:58 – Obesity Is a Chronic Disease
00:32:45 – Defining obesity
00:36:16 – The Role of Genetics in Obesity
00:38:59 – Lifestyle Factors Beyond Genetics
00:40:46 – Insurance Barriers & PBM Costs
00:44:37 – Anti-GLP-1 Bias in Healthcare
00:46:22 – Why Strength Training Matters
00:51:39 – New Doctors & Role of AI
00:53:38 – Protecting Muscle on GLP-1s
00:58:55 – No Shortcuts to Health
01:02:01 – The Vineyard
Show Links:
Glp-1s Can Help Employers Lower Medical Costs In 2 Years, New Study Finds
Further Listening
GLP1 Uncovered FREE 4 Part Video Series
Ozempic Done Right Playlist
EP. 202 | The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knap
Check Out Dr. Spencer
Vineyard
Website
Podcast
Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
7,238 Listeners
1,088 Listeners
4,909 Listeners
3,508 Listeners
9,305 Listeners
1,200 Listeners
616 Listeners
332 Listeners
590 Listeners
58 Listeners
513 Listeners
268 Listeners
1,145 Listeners
70 Listeners
245 Listeners